AstraZeneca has partnered with New Zealand-based Adherium Limited, which offers a mobile-enabled inhaler, to incorporate digital health offerings into AstraZeneca’s patient support programs for people ...
Smart inhaler company Adherium announced last week that it has received 510(k) clearance for over-the-counter sales of its inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, called ...
Tell us about the work you lead at AstraZeneca. I work on the development of inhalation devices for patients, mostly with COPD and asthma. There are a couple of different kinds of inhalers we are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results